ABCB1 and breast cancer: In addition, down-regulation of miR-200c was also observed in the MCF-7 breast cancer cell line resistant to doxorubicin, also being associated with a poor chemotherapy response in human breast cancer patients in part by a possible upregulation of ABCB1 expression[30].